4-(4-(1-Methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride

Catalog No. :
ACTRMJ339
CAS No. :
2007909-10-4
Molecular Formula :
C15H20ClN3
Molecular Weight :
277.80

IUPAC Name:4-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride

4-(4-(1-Methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$589.00Login to see priceInquiryInquiry
1g97%$1462.00Login to see priceInquiryInquiry
5g97%$4398.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-(1-Methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride
IUPAC Name4-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride
Molecular FormulaC15H20ClN3
Molecular Weight277.80
SMILESCN1N=CC(C2=CC=C(C3CCNCC3)C=C2)=C1.[H]Cl
InChI KeyKDWSCUQRPOVVDO-UHFFFAOYSA-N
Synonym4-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride(WXC05569);4-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidine hydrochloride;4-(4-(1-Methyl-1h-pyrazol-4-yl)phenyl)piperidine hcl
CAS No.2007909-10-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTRMJ339 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRMJ339 route product structure diagram
    ACTRMJ3392007909-10-4
Inquiry

2. ACTRMJ339 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACTRMJ339 route product structure diagram
    ACTRMJ3392007909-10-4
Inquiry

Comments (0)